Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimise treatment duration in genotype 1 non-cirrhotic treatment-naive patients with chronic hepatitis C virus
Fawsitt, C., Vickerman, P., Cooke, G., Welton, N.J.Volume:
68
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(18)30820-1
Date:
April, 2018
File:
PDF, 62 KB
english, 2018